Taysha Gene Therapies Inc...
1.63
0.01 (0.62%)
At close: Jan 15, 2025, 3:59 PM
1.63
0.31%
After-hours Jan 15, 2025, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 143.94M 87.88M 149.10M 251.25M n/a
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a 2.64M 2.64M n/a n/a
Other Long-Term Assets 2.46M 3.95M 1.11M 7.34M 15.00K
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 5.93M 8.54M 10.50M 6.63M 15.00K
Total Current Assets 149.87M 96.42M 159.60M 251.25M 15.00K
Property-Plant & Equipment 20.41M 25.91M 50.61M 287.00K n/a
Goodwill & Intangibles n/a -4.99M n/a n/a n/a
Total Long-Term Assets 22.86M 29.86M 54.35M 7.63M 15.00K
Total Assets 172.73M 126.28M 213.96M 258.88M 15.00K
Account Payables 6.37M 10.95M 21.76M 1.99M n/a
Deferred Revenue 18.11M 33.56M n/a n/a n/a
Short-Term Debt 1.65M 1.52M n/a n/a n/a
Other Current Liabilities 10.64M 16.77M 29.98M 5.13M 150.00K
Total Current Liabilities 36.76M 62.79M 51.75M 7.13M 150.00K
Long-Term Debt 59.46M 58.41M 63.09M n/a n/a
Other Long-Term Liabilities 1.58M 4.13M 3.73M 450.00K n/a
Total Long-Term Liabilities 61.04M 62.54M 66.83M 450.00K n/a
Total Liabilities 97.79M 125.33M 118.57M 7.58M 150.00K
Total Debt 61.11M 59.93M 63.09M n/a n/a
Common Stock 2.00K 1K n/a n/a n/a
Retained Earnings -513.01M -401.44M -235.65M -61.13M -1.11M
Comprehensive Income -0.00 -0.00 n/a -0.00 n/a
Shareholders Equity 74.94M 949.00K 95.38M 251.30M -135.00K
Total Investments 2.15M 2.64M 2.64M n/a n/a